Quick Takeaways: Why It Matters? By terminating the PrecisePRP arrangement with VetStem, PetVivo removes outstanding invoices, royalties and milestone overhangs from a non-core product line, which should simplify the story for investors and management while freeing attention and capital fo...
Quick Takeaways: Why It Matters? SilverCape’s lower $3.00/share proposal keeps PetMed Express in play as a potential takeout target, but the reduced price weakens the bid’s attractiveness and gives the board room to push for better terms or shop alternatives. Market-wise, it signals that a...
